Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Surg Oncol. 2006 Dec;32(10):1144-8. Epub 2006 Jul 26.

Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.

Author information

  • 1Department of Special Surgery, University of Padova Medical School, Via Giustiniani 2, 35100 Padova, Italy.

Abstract

AIM:

To investigate an "optimal" therapeutic management of patients with papillary thyroid microcarcinoma (PTMC).

METHODS:

We evaluated a group of 403 consecutive patients affected by PTMC operated on by the same surgeon. Prognostic factors were evaluated by uni- and multivariate statistical analysis.

RESULTS:

After a mean follow-up of 8.5 years, 372 patients were living without disease (undetectable serum thyroglobulin levels), 24 patients were living with disease (increased serum thyroglobulin levels), 6 patients were deceased due to causes different from thyroid cancer, and 1 patient was deceased due to metastatic thyroid cancer. No statistically significant prognostic factor was found at uni- and multivariate analysis. However, it is worth noting that in patients with a larger primary tumour (size> or =5mm) and treated by partial thyroidectomy alone, the prevalence of recurrent disease was higher than in patients treated by total thyroidectomy and (131)I administration.

CONCLUSION:

It appears reasonable to perform total thyroidectomy (possibly associated with central compartment node dissection), (131)I whole body scan (followed by (131)I therapy when necessary) and TSH-suppressive hormonal therapy in patients with PTMC.

PMID:
16872798
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk